Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin

Walker, Jaqui, Hutchison, Pippa, Ge, Junbo, Zhao, Dong, Wang, Yongjun, Rothwell, Peter M, Gaziano, J Michael, Chan, Andrew, Burn, John, Chia, John, Langley, Ruth, O'Donnell, Valerie Bridget ORCID: https://orcid.org/0000-0003-4089-8460, Rocca, Bianca and Hawkey, Chris 2018. Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin. ecancermedicalscience 12 , 813. 10.3332/ecancer.2018.813

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution. Download (158kB) | Preview

Abstract

Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow’s lecture hall at Charité, within Berlin’s Museum of Medical History, the International Aspirin Foundation’s 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin’s mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health. In addition to the delegates in Berlin, 300 medical doctors at the 19th Annual Scientific Congress of the Chinese Society of Cardiology were able to join the cardiology sessions from Taiyuan, Shangxi province via a live streaming link to and from China. This led to useful discussion and allowed a truly international perspective to the meeting.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Systems Immunity Research Institute (SIURI)
Additional Information:	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publisher:	European Institute of Oncology
ISSN:	1754-6605
Date of First Compliant Deposit:	29 March 2018
Date of Acceptance:	31 December 2017
Last Modified:	11 Nov 2023 15:12
URI:	https://orca.cardiff.ac.uk/id/eprint/110350

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item